Selective modification of antigen-specific CD4+ T cells by retroviral-mediated gene transfer and in vitro sensitization with dendritic cells

Clinical Immunology

Volumn 104, Issue 1, 2002, Pages 58-66

  Lin, Chun Ming ^a   Wang, Fu Hwei ^a  

^a SOOCHOW UNIVERSITY   (Taiwan)

Author keywords

Antigen specific T lymphocyte; Gene transfer; Retroviral vector

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RETROVIRUS VECTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DNA MODIFICATION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROVIRUS; SENSITIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

EID: 0036338351     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5229     Document Type: Article

References (64)

1. Immunotherapy and gene therapy of cancer
2. T cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes
3. Principles for adoptive T cell therapy of human viral diseases
4. Immunotherapy and gene therapy of cancer
5. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
6. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma
7. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
8. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
9. Rapid selection of antigen-specific T lymphocytes by retroviral transduction
10. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
11. Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells
12. Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
13. + T cells for efficient tumor cell lysis
14. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses
15. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors
16. Recognition of chronic myelogenous leukemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells
17. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
18. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
19. Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization
20. The fate of adoptively transferred antigen-specific T cells in vivo
21. In vivo migration and function of HIV-1-specific cytotoxic T cells
22. + CTL clone is limited by elimination due to encounter with HIV-infected targets
23. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells
24. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
25. Role of transforming growth factor-β in cancer
26. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
27. Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity
28. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
29. Integration of murine leukemia virus DNA depends on mitosis
30. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte response
31. CD4 T cells and their role in antitumor immune responses
32. + MHC class II-restricted T cells that are cytotoxic in vitro and tumoricidal in vivo
33. + T cells eliminate MHC class I-negative cancer cells in vivo by indirect effects of IFN-γ
34. The proto-oncogene Bcl-2 and its role in regulating apoptosis
35. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens
36. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improved survival in sepsis
37. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
38. Transfected human dendritic cells to induce antitumor immunity
39. Improved retroviral vectors for gene transfer and expression
40. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes
41. Virosomes: Cationic liposomes enhance retroviral transduction
42. Centrifugal enhancement of retroviral-mediated gene transfer
43. Regulation of lymphocyte survival by the bcl-2 gene family
44. Induction of apoptosis in Bacillus Calmette-Guerin-activated T cells by transforming growth factor-β
45. Transforming growth factor-β promotes death by neglect in post-activated human T cells
46. + T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-β: Implications for dendritic cell immunization against cancer
47. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis
48. TGF-β inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes
49. Transforming growth factor β from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes
50. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
51. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
52. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
53. Gene-modified dendritic cells for use in tumor vaccines
54. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
55. The endogenous pathway of MHC class II antigen presentation
56. Progress in human tumour immunology and immunotherapy
57. Phenotypic analysis of antigen-specific T lymphocytes
58. + T cells based on cytokine secretion
59. + cytomegalovirus phosphoprotein pp65 epitope determination
60. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells
61. Combination bacteriolytic therapy for the treatment of experimental tumors
62. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease
63. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
64. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection